Our Services
Medical Information
Helpful Resources
Published on: 9/15/2026
Stopping pregabalin abruptly is generally not recommended, because sudden discontinuation can trigger withdrawal symptoms such as anxiety, insomnia, nausea, sweating, headache, irritability, and in some cases seizures. Doctors usually advise tapering the dose gradually over at least one week, and often longer for higher doses, long-term use, or people with a seizure disorder. Risk levels differ depending on your dose, how long you have taken it, why it was prescribed, and other medications or conditions you have, so there are several important factors to consider before making any change. See below to understand how tapering schedules typically work, which withdrawal symptoms warrant urgent care, and when a return of your original pain, anxiety, or seizure symptoms may be the real issue.
If you are unsure whether your symptoms reflect withdrawal, a returning condition, or something unrelated, a free, instant, online symptom check can help you sort through the possibilities in a few minutes and see which next steps make sense, including whether to contact your prescriber now or seek emergency care.
Last reviewed for medical accuracy: 09/15/2026
Pregabalin is a medication commonly prescribed for nerve pain, epilepsy, and certain anxiety disorders. It’s important to understand that stopping pregabalin suddenly (cold turkey) can lead to uncomfortable or even serious withdrawal symptoms. This guide explains the risks, typical experiences, and safer ways to taper off pregabalin based on credible medical recommendations.
Pregabalin belongs to a class of drugs called gabapentinoids. It works by calming overactive nerves in the brain and spinal cord. Common uses include:
Pregabalin is effective when taken as directed, but long-term use can lead to physical dependence, meaning your body gets used to having the drug on board.
When you take pregabalin regularly, your nervous system adapts. Abruptly removing the drug can trigger a rebound effect, where nerve excitability surges beyond normal levels. Potential dangers of stopping cold turkey include:
These effects typically start within a day or two of the last dose and can last from several days up to a few weeks.
Everyone’s experience is unique, but common symptoms include:
Severe cases can involve confusion, hallucinations or seizure recurrence, which require immediate medical attention.
Medical guidelines recommend a gradual taper rather than abrupt cessation. Here’s a general approach—always tailor it with your doctor’s input:
Discuss your plan with a healthcare professional
A doctor will help decide the best tapering schedule, considering your current dose, how long you’ve been on pregabalin and your overall health.
Reduce the dose in small steps
Typical tapering might mean cutting your daily dose by about 10–25% every 1–2 weeks. Your doctor may adjust more slowly if withdrawal symptoms emerge.
Monitor symptoms closely
Keep a daily log of any new or worsening symptoms. This helps your doctor decide if the taper needs to slow down.
Adjust pace as needed
If symptoms become severe, your doctor may hold the dose or increase it slightly until you stabilize.
Consider supportive therapies
Cognitive-behavioral therapy (CBT), relaxation techniques or gentle exercise can ease anxiety and sleep problems during tapering.
Beyond a medical taper schedule, these self-care strategies can make withdrawal more manageable:
While mild to moderate withdrawal can feel unpleasant, certain signs warrant urgent medical attention:
If you experience any of these, call emergency services or go to your nearest hospital.
If you’re uncertain about your symptoms or need guidance on next steps, you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you understand possible causes and when to seek medical care. Free, online symptom check, using the doctor approved Ubie Symptom Checker
This information is intended as a general guide. Every person’s medical history and situation is different. Before changing your pregabalin dose or if you suspect serious withdrawal, please speak to a doctor. Only a qualified healthcare professional can provide personalized advice and ensure your safety.
Stopping pregabalin cold turkey is generally not recommended due to the risk of withdrawal symptoms and potential complications. A careful, doctor-supervised taper offers the safest route. With proper planning, support and monitoring, you can successfully discontinue pregabalin while minimizing discomfort and health risks.
(References)
* Atkin T, Comai S, Gobbi G. Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery. Pharmacol Rev. 2018 Apr;70(2):197-245. doi: 10.1124/pr.117.014381. PMID: 29487083.
* Hamed SA. Sexual Dysfunctions Induced by Pregabalin. Clin Neuropharmacol. 2018 Jul/Aug;41(4):116-122. doi: 10.1097/WNF.0000000000000286. PMID: 30001248.
* McPherson D, Wick JY. Gabapentin: Change is in the Wind. Sr Care Pharm. 2019 Sep 1;34(8):490-498. PMID: 31462352.
* Murphy R, McGuinness D, Hallahan B. Pregabalin-induced sexual disinhibition. Ir J Psychol Med. 2020 Mar;37(1):55-58. doi: 10.1017/ipm.2017.5. Epub 2017 Mar 8. PMID: 32223791.
* Salem Hareedy M, Mohamed Tawfik K, Badary DM, Ahmed Mahmoud W, Mohamed Mohamed EE. Pregabalin administration and withdrawal affect testicular structure and functions in rats. Andrologia. 2020 Dec;52(11):e13808. doi: 10.1111/and.13808. Epub 2020 Sep 3. PMID: 32882064.
* Zhang S. Chemotherapy-induced peripheral neuropathy and rehabilitation: A review. Semin Oncol. 2021 Jun;48(3):193-207. doi: 10.1053/j.seminoncol.2021.09.004. Epub 2021 Sep 22. PMID: 34607709.
* Çalışkan AM, İnanlı İ, Çalışkan S, Eren İ. Delirium After Pregabalin Withdrawal. Alpha Psychiatry. 2021 Mar;22(2):118-119. doi: 10.5455/apd.117770. Epub 2021 Mar 18. PMID: 36425938; PMCID: PMC9590627.
* Rissardo JP, Fornari Caprara AL, Bhal N, Repudi R, Zlatin L, Walker IM. Drug-Induced Myoclonus: A Systematic Review. Medicina (Kaunas). 2025 Jan 15;61(1). doi: 10.3390/medicina61010131. Epub 2025 Jan 15. PMID: 39859113; PMCID: PMC11767161.
* Piazza R, Weiss K, Rosemann T, Knechtle B. [Fluoroquinolone-associated disability after taking ciprofloxacin]. Praxis (Bern 1994). 2025 Sep;114(8-9):326-330. doi: 10.23785/PRAXIS.2025.08_09.005. PMID: 41017607.
* Winkelman JW, Wipper B. Restless Legs Syndrome: A Review. JAMA. 2026 Feb 24;335(8):703-714. doi: 10.1001/jama.2025.23247. PMID: 41563785.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.